

Trachoma is the result of infection of the eye with Chlamydia trachomatis (C. trachomatis). It is the leading cause of infectious blindness worldwide.1 In 2008, it has been estimated that 1.2 billion people live in endemic areas; 40.6 million people are suffering from active trachoma, and 8.2 million have trichiasis. More than 48 percent of the global burden of active trachoma is found in five countries: Ethiopia, India, Nigeria, Sudan, and Guinea. Fifty percent of the global burden of trichiasis is concentrated in three countries: China, Ethiopia, and Sudan.4 The World Health Organization (WHO) estimates that 8 million people worldwide have been visually impaired by trachoma.2 In Africa, the prevalence of infection has been shown to reach 40 percent.3 The economic impact of trachoma has been estimated at $2.9 billion per year.

C. trachomatis spreads through direct contact with the eye, nose, or throat secretions of infected people. It is very contagious and almost always affects both eyes. Infection is frequently passed from child to child and from child to mother, especially where there are shortages of water, numerous flies, and crowded living conditions.1
WHO, in 1997, established the Alliance for Global Elimination of Trachoma (GET) by the year 2020.5 The elimination strategy has been summarized with the acronym SAFE, which stands for Surgery for trichiasis, Antibiotics for active infection, Facial cleanliness and Environmental change.5
Learn more about Trachoma: